Clinical trials
Not yet recruiting Non-alcoholic Fatty Liver Disease trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
55 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2018 | 1 |
| 2021 | 1 |
| 2023 | 4 |
| 2024 | 7 |
| 2025 | 11 |
| 2026 | 29 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Not yet recruiting | 55 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Assiut University | 12 |
| Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis | 2 |
| Regeneron Pharmaceuticals | 2 |
| Ain Shams University | 1 |
| Arrowhead Pharmaceuticals | 1 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| Badr University | 1 |
| Central Hospital, Nancy, France | 1 |
| Columbia University | 1 |
| Cyprus University of Technology | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Non-alcoholic Fatty Liver Disease | 55 |
| Fatty Liver | 11 |
| Liver Cirrhosis | 10 |
| Obesity | 8 |
| Fibrosis | 5 |
| Metabolic Syndrome | 5 |
| Diabetes Mellitus, Type 2 | 4 |
| Hypothyroidism | 2 |
| Insulin Resistance | 2 |
| Liver Diseases | 2 |
Trials
Showing 51 to 55 of 55. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.